AboutApproachTeamPortfolioNews
Contact Us
LinkedIn

Enabling visionaries on the frontiers of deep technology. 

We are
Celesta Capital.

Founders need more than capital alone to build a great company. It takes a partner who understands the entrepreneurial journey and knows what it takes to succeed.
‍
We specialize in supporting bold founders within deep tech–the technological engine that powers our modern world. 

About Celesta→︁
AboutInsightsPortfolioApproachNews
AboutInsightsPortfolioApproachNews

Why we invested in Baffle. 

Baffle is the only data-centric security solution that universally protects data as it’s created, stored, and processed, from any source to any destination. Learn more about why we invested.

LEARN MORE→︁
AboutInsightsPortfolioApproachNews

Pyxis One 

Pyxis One enables brands to scale accurate, data-driven marketing using artificial intelligence. Here's why we invested.

Learn More→︁

AI Infrastructure for Marketing

Pyxis is a SaaS company focused on improving digital advertising ROI through an end-to-end AI marketing cloud.

Learn more→︁

AI for Breast Cancer Detection

WhiteRabbit.ai is a healthcare company focused on early and accurate cancer detection enhanced by deep learning software.

Learn more→︁

High Performance Switch Silicon

Innovium is a semiconductor company driving efficient resource sharing and freeing data flow in hyperscale networks.

Learn more→︁

A Better Way to Run Kubernetes

Platform9 is the leading Managed Kubernetes provider for private, edge, and hybrid clouds.

Learn more→︁

Building The Supersonic Future

Boom is an aviation company working to reduce flight times for long-haul flights, dramatically altering the cost-benefit of long-distance air travel.

Learn more→︁

Daring founders.
Landscape-
shifting technologies.

Explore more companies laying the groundwork for the next generation of technological advancements.

explore our portfolio→︁

Where and how we invest.

Our team's decades of technology, operating, and investing experience help nurture some of today’s most promising companies around the globe.

Investment approach→︁
3
FUNDS
$600M
CAPITAL COMMITTED
75+
COMPANIES
8
COUNTRIES INVESTED
16
EXITS
25
Investments 3X Entry Valuation
AboutInsightsPortfolioApproachNews

The latest from Celesta
and our portfolio companies. 

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

Stellapps: Why We Invested

Berkeley Lights Pre-Announced Outstanding Q3 Results

Q&A with Rizzle Co-Founder Vidya Narayanan

READ MORE→︁
AboutInsightsPortfolioApproachNews
We transform potential into brilliance.